Results 31 to 40 of about 2,876 (190)
Кардиоваскулярная терапия и профилактика, 2011 Angiotensin II receptor blockers (ARBs) have been available in the United Statessince 1995. These agents have demonstrated antihypertensive efficacy at least similar to that of agents from other antihypertensive classes.
M. Greathouse
doaj +1 more source
Future Journal of Pharmaceutical Sciences, 2021 Background Nowadays combination therapy has become more popular due to their additional effect, synergistic effect and antagonistic effect. Any of these can influence the treatment profile.
Matrika Saha Roy +8 more
doaj +1 more source
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations. [PDF]
, 2023 Blood pressure control remains an unmet clinical need. Only about half of patients achieve their blood pressure (BP) targets and of these, the majority require combination and double or triple therapies. International guidelines recommend the association
Burnier, M., Redon, J., Volpe, M.
core +1 more source
Learning Health Systems, Volume 10, Issue 1, January 2026.ABSTRACT Introduction Despite strong evidence supporting guideline‐directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF), a significant gap persists in the consistent application of these therapies. This shortfall has prompted organizations like the American College of Cardiology to recommend leveraging electronic ...
Joey LeGrand +5 more
wiley +1 more source
The use of nanotechnology in cardiovascular disease [PDF]
, 2018 Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the ...
Chandarana, M, Curtis, A, Hoskins, C
core +3 more sources
Clinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1463-1476, December 2025.Overview of a multi‐omics based drug repurposing strategy. The systematic drug repurposing strategy included the following steps: (1) osteoporosis driver signaling networks were identified from multi‐omics data; (2) drug functional modules were obtained using a network fusion approach to integrate drug similarity information; (3) all drugs were ranked ...
Dan‐Yang Liu +21 more
wiley +1 more source
Looking for an optimal antihypertensive combination. Focus on azilsartan medoxomil/chlorthalidone
Российский кардиологический журналThe article analyzes data from clinical studies on the efficacy and safety of azilsartan medoxomil/chlorthalidone combination and its components. According to the analyzed sources, both individual components and their combination have proven their ...
M. D. Smirnova +2 more
doaj +1 more source
Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
Química Nova, 2013 A stability-indicating method using MEKC was validated for the analysis of olmesartan medoxomil in tablets. Successful separation was achieved using a fused silica capillary (40 cm x 50 µm i.d.); background electrolyte consisted of a combination of 10 ...
Lisiane Bajerski +8 more
doaj +3 more sources
Epidemiology and Management of Hypertension in the Hispanic Population [PDF]
, 2012 Hispanics are the fastest growing ethnic minority in the USA. Among Hispanics, lack of hypertension awareness and lack of effective blood pressure (BP) control are problematic, as are higher incidence rates of hypertension-related co-morbidities compared
Nicolas J. Guzman
core +1 more source
Clinical Case Reports, Volume 13, Issue 9, September 2025.ABSTRACT We report a case of pseudo‐hypoaldosteronism type 2 (PHA II) in a hypertensive 55‐year‐old woman who carried new variants of the KLHL3 gene. Hypersensitivity to hydrochlorothiazide was noted. Low dosages of hydrochlorothiazide were needed to restore potassium levels.
Massimo Giusti +2 more
wiley +1 more source